289 related articles for article (PubMed ID: 8846536)
21. Iron-replete hemodialysis patients do not require higher EPO dosages when converting from subcutaneous to intravenous administration: results of the Italian Study on Erythropoietin Converting (ISEC).
Pizzarelli F; David S; Sala P; Icardi A; Casani A
Am J Kidney Dis; 2006 Jun; 47(6):1027-35. PubMed ID: 16731298
[TBL] [Abstract][Full Text] [Related]
22. [The effect of treatment with human recombinant erythropoietin on the functional status of patients on maintenance hemodialysis].
Ermolenko VM; Lashutin SV; Rudakov AG; Fel'd BN; Manakova TE; Kukhtevich AV; Kondakhchan MA; Romanenko NG
Ter Arkh; 1991; 63(6):81-6. PubMed ID: 1948755
[TBL] [Abstract][Full Text] [Related]
23. Serum erythropoietin concentrations in patients with anemia--preliminary hemoglobin-related reference ranges.
Vogeser M; Schiel X
Clin Lab; 2002; 48(11-12):595-8. PubMed ID: 12465743
[TBL] [Abstract][Full Text] [Related]
24. Secondary effects of erythropoietin treatment on metabolism and dialysis efficiency in stable hemodialysis patients.
Buur T; Lundberg M
Clin Nephrol; 1990 Nov; 34(5):230-5. PubMed ID: 2268981
[TBL] [Abstract][Full Text] [Related]
25. The effect of i.v. iron alone or in combination with low-dose erythropoietin in the rapid correction of anemia of chronic renal failure in the predialysis period.
Silverberg DS; Blum M; Agbaria Z; Deutsch V; Irony M; Schwartz D; Baruch R; Yachnin T; Steinbruch S; Iaina A
Clin Nephrol; 2001 Mar; 55(3):212-9. PubMed ID: 11316241
[TBL] [Abstract][Full Text] [Related]
26. Serum erythropoietin levels and their correlation with the erythropoietic system in hemodialysis patients and renal allograft recipients.
Khosroshahi HT; Shoja MM; Tubbs RS; Estakhri R; Ardalan MR
Transplant Proc; 2007 May; 39(4):1051-3. PubMed ID: 17524889
[TBL] [Abstract][Full Text] [Related]
27. Efficacy of intravenous methoxy polyethylene glycol-epoetin beta administered every 2 weeks compared with epoetin administered 3 times weekly in patients treated by hemodialysis or peritoneal dialysis: a randomized trial.
Klinger M; Arias M; Vargemezis V; Besarab A; Sulowicz W; Gerntholtz T; Ciechanowski K; Dougherty FC; Beyer U
Am J Kidney Dis; 2007 Dec; 50(6):989-1000. PubMed ID: 18037099
[TBL] [Abstract][Full Text] [Related]
28. Effects of erythropoietin on glucose tolerance in hemodialysis patients.
Chagnac A; Weinstein T; Zevin D; Korzets A; Hirsh J; Gafter U; Levi J
Clin Nephrol; 1994 Dec; 42(6):398-400. PubMed ID: 7882604
[TBL] [Abstract][Full Text] [Related]
29. [Effectiveness of and tolerance to human recombinant erythropoietin in the treatment of kidney failure anemia in children undergoing continuous peritoneal dialysis. Multicenter study].
Parchoux B; Broyer M; Cochat P; Burguet A; Menget A; Benoît D; Nivet H; Fischbach M; Geisert J; Dabout D
Pediatrie; 1993; 48(5):397-401. PubMed ID: 7777395
[TBL] [Abstract][Full Text] [Related]
30. Erythropoietin treatment improves quality of life in hemodialysis patients.
Bárány P; Pettersson E; Bergström J
Scand J Urol Nephrol Suppl; 1990; 131():55-60. PubMed ID: 2075471
[TBL] [Abstract][Full Text] [Related]
31. [Optimal therapy with erythropoietin (EPO) in patients with renal anemia on hemodialysis therapy].
Merta M; Sobotová D; Zahálková J; Bitterová Z; Jirka T; Knetl P; Kopenec J; Suchanová J; Vlasák J
Sb Lek; 2001; 102(1):41-52. PubMed ID: 11830918
[TBL] [Abstract][Full Text] [Related]
32. The effect of high-flux hemodialysis on renal anemia.
Ayli D; Ayli M; Azak A; Yüksel C; Kosmaz GP; Atilgan G; Dede F; Abayli E; Camlibel M
J Nephrol; 2004; 17(5):701-6. PubMed ID: 15593038
[TBL] [Abstract][Full Text] [Related]
33. Endogenous erythropoietin levels and anemia in long-term renal transplant recipients.
Zadrazil J; Horák P; Horcicka V; Zahálková J; Strébl P; Hrubý M
Kidney Blood Press Res; 2007; 30(2):108-16. PubMed ID: 17374961
[TBL] [Abstract][Full Text] [Related]
34. [Effect of recombinant human erythropoietin (rEPO) on angina pectoris in patients with chronic maintenance hemodialysis].
Imamura Y; Hase H
Nihon Jinzo Gakkai Shi; 1991 Apr; 33(4):403-8. PubMed ID: 1875559
[TBL] [Abstract][Full Text] [Related]
35. Administration of exogenous erythropoietin beta affects lipid peroxidation and serum paraoxonase-1 activity and concentration in predialysis patients with chronic renal disease and anaemia.
Marsillach J; Martínez-Vea A; Marcas L; Mackness B; Mackness M; Ferré N; Joven J; Camps J
Clin Exp Pharmacol Physiol; 2007 Apr; 34(4):347-9. PubMed ID: 17324148
[TBL] [Abstract][Full Text] [Related]
36. Influence of erythropoietin treatment on 2,3-bisphosphoglycerate and O2-affinity of red blood cells in children with renal anemia.
Rapoport I; Engelhardt I; Drung I; Holzhütter H; Schmidt G
Biomed Biochim Acta; 1990; 49(2-3):S280-3. PubMed ID: 2386518
[TBL] [Abstract][Full Text] [Related]
37. Are hematinic deficiencies the cause of anemia in chronic heart failure?
Witte KK; Desilva R; Chattopadhyay S; Ghosh J; Cleland JG; Clark AL
Am Heart J; 2004 May; 147(5):924-30. PubMed ID: 15131553
[TBL] [Abstract][Full Text] [Related]
38. Effects of erythropoietin on strength and functional status of patients on hemodialysis.
Guthrie M; Cardenas D; Eschbach JW; Haley NR; Robertson HT; Evans RW
Clin Nephrol; 1993 Feb; 39(2):97-102. PubMed ID: 8448925
[TBL] [Abstract][Full Text] [Related]
39. Concentrations of lactate and pyruvate in maternal and neonatal blood with different intravenous fluids used for prehydration before epidural anesthesia.
Ramanathan S; Masih AK; Ashok U; Arismendy J; Turndorf H
Anesth Analg; 1984 Jan; 63(1):69-74. PubMed ID: 6691565
[TBL] [Abstract][Full Text] [Related]
40. Successful treatment of refractory anemia with a combination regimen containing recombinant human erythropoietin, low-dose methylprednisolone and nandrolone.
Tsiara SN; Chaidos A; Gouva M; Christou L; Panteli K; Kapsali E; Bourantas KL
J Exp Clin Cancer Res; 2004 Mar; 23(1):47-52. PubMed ID: 15149150
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]